Jovanche Vitanovski/123rf.comParis-based One Biosciences, a pioneering “techbio” company at the intersection of artificial intelligence and oncology, has announced a €15 million Series A funding round to accelerate the clinical application of its flagship technology.
Tag Archive for: AI
Max Kratzer / PlectonicUnder a new partnership, Plectonic Biotech will use Sonrai’s AI-powered multi-omics platform to speed up development of its Logybody cancer treatment technology. The approach aims to cut side effects and improve precision.
Indivumed GmbHThe Hamburg-based company Indivumed has repositioned itself, sending a clear message with a recent change in leadership: A new chapter is beginning with the focus on discovering and developing novel therapeutic targets for innovative cancer therapies. |transkript spoke with Prof. Dr. Hartmut Juhl and Dr. Matthias Evers.
BioNTechBioNTech is set to open a research centre for cancer therapy in the United Kingdom, much to the delight of the British government, which is helping pave the way with a substantial financial boost.
Minos Biosciences SASOnly three weeks to go until Europe’s largest event for laboratory automation and drug screening. SLAS Europe 2025, organised by the Society for Laboratory Automation and Screening (SLAS), will take place in Hamburg from 20-22 May. In a series, European Biotechnology Magazine presents the 12 most innovative SMEs today: French Minos Biosciences SAS.
Tenthpin GroupThe much-discussed digital transformation in the healthcare sector is in full swing. European Biotechnology spoke with Dr. Sabrina Graf, COO of the globally active Tenthpin Group, about how the right software can improve quality management, keep the system landscape lean, and safe both, time and money.
Brainomix Ltd.University of Oxford spinout Brainomix Ltd has closed a £14m Series C round to advance its commercial expansion in the US. Funding will also support clinical uptake of its AI imaging technology in stroke and lung fibrosis.
Cradle.bioThe Dutch-Swiss company with operations also in Zurich, Switzerland, has raised US$73m in a Series B and will continue to expand its AI research, sales, and operations teams. The new announcement comes around a year after raising €21.92m in a Series A funding round.
BIOCOMBiotech CSOs, CDMOs, CROs, lab specialists and AI developers gave an in-depth insight into next-generation antibody-based therapies to about 1,500 attendees at the 16th PEGS Europe in Barcelona. Several new formats are expected to enter the market in the next few years, promising to significantly reduce the side effects of CAR-Ts, bispecific antibodies, ADCs, etc. and improve their efficacy.
Knowledge Seeker - wikipedia.orgDigital pathology specialist AIgnostics GmbH has topped up its cash position to US$55m with a US$34m Series B financing. The money will be used to optimise the company’s RudolfV Foundation Model and to develop and offer new services for target and biomarker identification selection, particularly in the US pharma market.
Tag Archive for: AI
Last year, potency assays as a new conference topic was very well received by attendees. It will therefore be offered again this year. Further, according to the general feedback, there is also a need for conferences on other topics as a platform for exchanging experiences and opinions with colleagues and regulatory representatives. Accordingly, in 2025, three new topics will be addressed in dedicated tracks:
• Bioanalytical Control of Biological Drug Substances and Products
• Quality Control of mRNA/LNP Products (Pre-Conference, 24 November)
• Artificial Intelligence in Laboratories
The established topics will also be covered at PharmaLab 2025 from 24-26 November in Neuss – providing participants with the opportunity to exchange knowledge and experiences with representatives from authorities like EDQM, PEI, NIBSC/MHRA, AGES, industrial experts and scientists from laboratories:
• Analytical Quality and Lifecycle Concepts
• GMP Compliance Trends Analytical Laboratories
• Laboratory Optimization, Automation and Digitalization/Outsourcing in Pharmaceutical Laboratories
• Endotoxin and Pyrogen Testing
• Alternative and Rapid Microbiological Methods
• Cell and Gene Therapies/ ATMPs – Quality and Safety
• Bioassays/Potency Assays – Regulatory Requirements, Developments and Routine Use
• 6th International Mycoplasma qPCR Testing User Day (Pre-Conference, 24 November)
Congress delegates benefit from 9 parallel conferences, 2 pre-conference workshops with altogether over 100 presentations, 50 exhibitors in the exhibition and the networking event. An update in all relevant areas of pharmaceutical lab developments will be provided.
One-day and multi-day tickets offer participants the opportunity to attend parts or even the entire congress and thereby put together an individual programme with the lectures of choice.
More information
Website: https://www.pharmalab-congress.com
eMail: info(at)concept-heidelberg.de